U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 20:38:12 GMT 2025
Edited
by admin
on Mon Mar 31 20:38:12 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin MOUSE CHIMERIC
Sequence Type COMPLETE
Record UNII
T4H8FMA7IM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SILTUXIMAB
DASH   INN   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
SYLVANT
Preferred Name English
SILTUXIMAB [VANDF]
Common Name English
SILTUXIMAB [USAN]
Common Name English
siltuximab [INN]
Common Name English
CNTO-328
Code English
SILTUXIMAB [MI]
Common Name English
SILTUXIMAB [PURPLE BOOK CDER]
Common Name English
CNTO328
Code English
CLLB8
Code English
Siltuximab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6) (HUMAN-MOUSE MONOCLONAL CNTO 328 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CNTO 328 K-CHAIN, DIMER
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
EU-Orphan Drug EU/3/07/508
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
FDA ORPHAN DRUG 200505
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
FDA ORPHAN DRUG 200605
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
EMA ASSESSMENT REPORTS SYLVANT (AUTHORIZED: GIANT LYMPH NODE HYPERPLASIA)
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
WHO-ATC L04AC11
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
NDF-RT N0000191006
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
Code System Code Type Description
FDA UNII
T4H8FMA7IM
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
MERCK INDEX
m11726
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
NCI_THESAURUS
C61084
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
LACTMED
Siltuximab
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
CAS
541502-14-1
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
IUPHAR
7396
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
USAN
WW-87
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
DRUG BANK
DB09036
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
WIKIPEDIA
SILTUXIMAB
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743070
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
EVMPD
SUB32552
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
DAILYMED
T4H8FMA7IM
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
SMS_ID
100000124530
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
RXCUI
1535218
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY RxNorm
NDF-RT
N0000191004
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY Interleukin-6 Antagonists [MoA]
DRUG CENTRAL
4977
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
INN
9051
Created by admin on Mon Mar 31 20:38:12 GMT 2025 , Edited by admin on Mon Mar 31 20:38:12 GMT 2025
PRIMARY
From To
1_22 1_96
1_146 1_202
1_263 1_323
1_369 1_427
2_22 2_96
2_146 2_202
2_263 2_323
2_369 2_427
3_23 3_87
3_133 3_193
4_23 4_87
4_133 4_193
1_222 3_213
2_222 4_213
1_228 2_228
1_231 2_231
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL